Gurugram, 14th June 2023: A 41-year-old female got a new lease of life after she was timely treated for stage IV Triple Negative Breast Cancer (TNBC). The Bihar based patient was referred to American Oncology Institute (AOI), Gurugram, for treatment by Senior Consultant Medical and Hemato Oncology, Dr (Brig) A.K. Dhar. This case marks a significant milestone in the fight against TNBC, which is known for being particularly difficult to treat.
Globally, Breast cancer is the commonest malignancy among women. The Globocan data 2020 has revealed that in India, Breast Cancer Constitutes 13.5% of all cancer cases and is responsible for 10.6% of all cancer deaths. There are four types of breast cancers depending upon sensitivity of hormone receptors. of these, TNBC is the most aggressive and has faster growth rate, higher risk of metastasis, higher recurrence rate and is harder to treat. TNBC accounts for around 15-20% of all breast cancer diagnoses.
Dr (Brig) A.K. Dhar, Senior Consultant Medical and Haemato Oncology, said, "We are thrilled with the outcome of this treatment and are proud of our patient's strength and perseverance throughout the process. This case demonstrates that with the right treatment plan and medical care, TNBC can be successfully treated even at advanced stages. This successful treatment gives hope to other TNBC patients and their families who are battling this aggressive form of breast cancer.”
Mrs. Neha Singh (name changed) was presented with a complaint of Breast lump right side existing for about one and half year’s duration. Further clinical examination showed a hard lump in upper outer quadrant Right breast measuring 5x4 cm. She also had extensive liver and skeletal metastasis. After investigation, she was diagnosed with triple negative metastatic cancer of the right breast (stage IV). It tends to behave more aggressively than other types of breast cancers. She underwent rigorous chemotherapy, a treatment plan tailored to the patient's unique medical needs and received regular medical checkups and follow-up care to monitor her progress. After six months of treatment, the patient's tumor size decreased significantly, and the cancer cells were no longer detectable in her blood work.
Dr Amit Dhawan, Regional COO, American Oncology Institute, Gurugram, said, “We will continue to work towards developing more effective treatment options for TNBC, but for now, this case provides a glimmer of hope. American Oncology Institute (AOI) has always been at the forefront of providing quality healthcare that is on par with state-of-the-art infrastructure and international standards. We are committed to offering best-in-class clinical expertise, technological superiority, and service excellence for our patients.”
American Oncology Institute (AOI) at Aarvy Healthcare Super Specialty Hospital is one of the best cancer hospital in Gurugram, North India. It offers world-class cancer care treatments and diagnostics in Gurugram and the neighboring states. American Oncology Institute (AOI) brings with it the network of super-specialty cancer hospitals in India and South Asia.
